Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
Safety Study of Recombinant Interferon Variant(PEG-IFN-SA) to Treat HCV Disease (NCT01605513)The First Hospital of Jilin University2011-06-01
Evaluating Dose-proportionality of Dilatrend Suspended-Release Capsule (NCT01369472)Chong Kun Dang Pharmaceutical2011-06-01
Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of LC350189 (NCT01361646)LG Life Sciences2011-06-01
Ascending Single-Dose Study to Evaluate VIA-3196 in Healthy Subjects (NCT01367873)Madrigal Pharmaceuticals, Inc.2011-06-01
Single Dose Study in Healthy Participants to Investigate the Safety and Absorption of LY2584702 (NCT01372085)Eli Lilly and Company2011-06-01
The Efficacy and Safety Study of a New Cross-linked Hyaluronan Hydrogel in the Reduction of Postsurgical Peritoneal Adhesions (NCT02166554)BioRegen Biomedical (Changzhou) Co., Ltd2011-06-01
Absolute Bioavailability Study With Ipragliflozin (NCT01611428)Astellas Pharma Europe B.V.2011-06-01
MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E Mutations (NCT01352273)Array Biopharma, now a wholly owned subsidiary of Pfizer2011-06-01
Multiple Ascending Dose Trial of BYK324677 in Healthy Volunteers (NCT01386541)Nycomed2011-06-01
Disposition of Carbon-14-Labeled LY2886721 ([^14C]-LY2886721) Following Oral Administration in Healthy Human Participants (NCT01367262)Eli Lilly and Company2011-06-01
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1029 in Participants With Mild to Moderate Asthma (NCT01370317)Merck Sharp & Dohme LLC2011-06-01
Phase I Study of AbGn-168H in Healthy Male Volunteers (NCT01378364)Boehringer Ingelheim2011-06-01
A Phase I Clinical Trial to Evaluate the Effect of Renal Impairment on Pharmacokinetics of NOX-E36 (NCT01372124)TME Pharma AG2011-06-01
Pharmacokinetic Assessment of Simultaneous Administration of Clopidogrel and Aspirin (NCT01388660)Ajou University School of Medicine2011-06-01
A Phase I Study to Evaluate Safety, Tolerability and Pharmacokinetics of ONO-4053 in Healthy Volunteers (NCT01379586)Ono Pharmaceutical Co., Ltd.2011-06-01
The Safety and Tolerability of PF-05089771 Will be Investigated in Healthy Subjects Over a 14 Day Dosing Period. (NCT01365637)Pfizer2011-06-01
Clinical Trial to Assess the Efficacy and Safety of a Novel Cellulite Cream (NCT01562470)Nutrasource Pharmaceutical and Nutraceutical Services, Inc.2011-06-01
Sublingual Immunotherapy for Peanut Allergy and Induction of Tolerance (NCT01373242)University of North Carolina, Chapel Hill2011-06-01
A Study to Evaluate the Effect of JNJ-28431754 (Canagliflozin) on Post-Meal Glucose in Patients With Type 2 Diabetes Mellitus (NCT01381887)Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2011-06-01
Effects of Contingency Management and Nicotine Replacement Therapy on Youth Smoking (NCT01359709)University of California, Los Angeles2011-06-01
Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Repeated Doses of PF-04958242 in Healthy Volunteers (NCT01511510)Biogen2011-06-01
Assessment of Relative Bioavailability of NKTR-118 in Three Formulations in Healthy Subjects (NCT01365000)AstraZeneca2011-06-01
A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer (NCT01373164)Eli Lilly and Company2011-06-01
Relative Bioavailability Study of Lipidil® Supra (Fenofibrate 160mg) Versus SYO-0805 (Fenofibrate 65mg) (NCT01353404)Samyang Biopharmaceuticals Corporation2011-06-01
An Open-Label Study of Intravenous BAL101553 in Adult Patients With Solid Tumors (NCT01397929)Basilea Pharmaceutica2011-06-01
Safety, Pharmacokinetics and Pharmacodynamics After Single and Multiple Dosing of AZD5423 in Japanese Healthy Male Subjects (NCT01338350)AstraZeneca2011-06-01
A Study of the Safety and Biological Activity of Intraperitoneal (IP) EGEN-001 Administered Alone and in Combination With Standard Chemotherapy in Colorectal Peritoneal Carcinomatosis Patients (NCT01300858)EGEN, Inc.2011-06-01
A Study of the Pharmacokinetics and Safety of Varespladib in Subjects With Normal or Impaired Renal Function (NCT01359579)Anthera Pharmaceuticals2011-06-01
Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate Cancer (NCT01335204)Medical University of South Carolina2011-06-01
A Study to Investigate How JNJ-38518168 May Affect the Plasma Levels of Methotrexate in Rheumatoid Arthritis Participants (NCT01450982)Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2011-06-01
Polyinosinic-Polycytidylic Acid-poly-L-lysine Carboxymethylcellulose (Poly-ICLC) in Healthy Volunteers (NCT01299662)Rockefeller University2011-06-01
Comparative Glucose Clamp Study of Wockhardt's Recombinant Insulin Analog Glargine(Glaritus) With Lantus in T1DM (NCT01357603)Wockhardt2011-06-01
A Metabolite Identification, Mass Balance, and PK Study of [14C]-Asimadoline to Healthy Adult Male Volunteers (NCT01380561)Tioga Pharmaceuticals2011-06-01
Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectable Esophageal Cancer (NCT01386346)Weill Medical College of Cornell University2011-06-01
Early Use of Rosuvastatin in Acute Coronary Syndromes: Targeting Platelet-Leukocyte Interactions (NCT01241903)Susan Smyth2011-06-01
Acceptability and Effectiveness of Household Water Treatment in Reducing Diarrhea Among Under Five Children (NCT01376440)Haramaya Unversity2011-06-01
Topical Interferon Gamma for Macular Edema Secondary to Uveitis (NCT01376362)National Eye Institute (NEI)2011-06-01
Safety and Immunogenicity of Malaria Vaccines AdCh63 AMA1, MVA AMA1 and AMA1-C1/Alhydrogel®+/- CPG 7909 (NCT01351948)University of Oxford2011-06-01
Evaluation of the Pharmacokinetics of Ulimorelin in Subjects With Hepatic Impairment and Healthy Subjects (NCT01405599)Norgine2011-06-01
Study of PWT33597 Mesylate in Subjects With Advanced Malignancies (NCT01407380)Pathway Therapeutics, Inc.2011-06-01
A Pharmacokinetic Study of RO4917523 in Healthy Japanese and Caucasian Subjects (NCT01368926)Hoffmann-La Roche2011-06-01
Safety Study of Single Administration Intravenous Treatment for Influenza (NCT01375985)Sarepta Therapeutics, Inc.2011-06-01
Bioequivalence Study of Fixed-dose Combinations and Coadministered Individual Tablets of Saxagliptin/Metformin-Brazil (NCT01365091)AstraZeneca2011-06-01
Enhancing Treatment of Iron Deficiency and Iron Deficiency Anemia With an Antioxidant, Vitamin E (NCT01700426)University of Colorado, Denver2011-06-01
Dolutegravir Renal Impairment Study (NCT01353716)ViiV Healthcare2011-06-01
A Single Dose Study In Japanese And Western Healthy Subjects To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-04991532 (NCT01369277)Pfizer2011-06-01
Effect Of CP-690,550 On The Pharmacokinetics Of Metformin In Healthy Volunteers (NCT01405118)Pfizer2011-06-01
Efficiency Comparison Between Methylprednisolone and Phenol 8% Treatment Using a Trans Sacral Approach - on Lower Back Pain and Limbs (NCT01468415)Assaf-Harofeh Medical Center2011-06-01
A Study of LY2216684 in Healthy Participants (NCT01380691)Eli Lilly and Company2011-06-01
Use of Granulocyte Colony-stimulating Factor for the Treatment of Recurrent Implantation Failure in IVF Patients (NCT01315470)Hadassah Medical Organization2011-06-01
TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck (NCT01334177)University of Washington2011-06-01
Assessment for Tachyphylaxis to Topical Corticosteroids in the Treatment of Psoriasis (NCT01404338)Patel, Rita Vikram, M.D.2011-06-01
Pharmacokinetic Properties of Isosorbide-5-mononitrate Under Fasting and Fed Condition in Healthy Male Subjects (NCT02101710)UCB Korea Co., Ltd.2011-06-01
Bioequivalence Study of Levetiracetam Tablet and Intravenous Infusion in Healthy Japanese Subjects (NCT01394224)UCB Pharma2011-06-01
SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer (NCT01542294)Chinese Academy of Medical Sciences2011-06-01
A Study Intended to Evaluate Safety, Tolerability and Pharmacokinetics (PK) Parameters of BL-1021 (NCT01121380)BioLineRx, Ltd.2011-06-01
Phase I/II Study to Assess the Safety and Activity of Enhanced TCR Transduced Autologous T Cells in Metastatic Melanoma (NCT01350401)Adaptimmune2011-06-01
Airway and/or Pulmonary Vessels Transplantation (NCT01331863)Assistance Publique - Hôpitaux de Paris2011-05-31
An Investigation of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2245035 in Healthy Volunteers and Allergic Rhinitics. (NCT01480271)GlaxoSmithKline2011-05-30
Combination Trial of Pimasertib (MSC1936369B) With Temsirolimus (NCT01378377)EMD Serono2011-05-27
Amoxicillin Bioequivalence Study Brazil - Fast (NCT01431989)GlaxoSmithKline2011-05-27
Genetics of the Acute Response to Alcohol in Social Drinkers (NCT01375556)National Institute on Alcohol Abuse and Alcoholism (NIAAA)2011-05-26
Effect of Aerobic Exercise Training on Cardiorespiratory Function in Patients With Traumatic Brain Injury (NCT01294332)National Institutes of Health Clinical Center (CC)2011-05-26
Glyburide Advantage in Malignant Edema and Stroke Pilot (NCT01268683)Remedy Pharmaceuticals, Inc.2011-05-26
Study Escalating Doses of PM01183 in Combination With Fixed Doxorubicin in Patients With Specific Advanced Unresectable Solid Tumors (NCT01970540)PharmaMar2011-05-25
Cediranib Maleate and Selumetinib Sulfate in Treating Patients With Solid Malignancies (NCT01364051)National Cancer Institute (NCI)2011-05-25
Combination of Pentostatin, Bendamustine and Ofatumumab for Treatment of Chronic Lymphocytic Leukemia and Lymphoma (NCT01352312)Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University2011-05-25
A Phase 1, Dose-escalation Study of MEDI-551 in Japanese Adult Patients With Relapsed or Refractory Advanced B-cell Malignancies (NCT01957579)AstraZeneca2011-05-25
A Study of LY2881835 in Healthy People and People With Diabetes (NCT01358981)Eli Lilly and Company2011-05-24
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma (NCT01328626)AbbVie2011-05-23
Healthy Volunteer Study Using 3 Different Formulations of Firategrast (NCT01416363)GlaxoSmithKline2011-05-20
A Study to Evaluate the Effect of Intravenous Zanamivir on Cardiac Conduction in Healthy Volunteers (NCT01353729)GlaxoSmithKline2011-05-19
PercutaneOus StEm Cell Injection Delivery Effects On Neomyogenesis in Dilated CardioMyopathy (The POSEIDON-DCM Study) (NCT01392625)Joshua M Hare2011-05-19
Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous Meningitis (NCT01373710)Institut Curie2011-05-19
Single Agent Armodafinil for Patient-Reported Fatigue Following Radiation Therapy for Head and Neck Cancer (NCT01330446)M.D. Anderson Cancer Center2011-05-19
Shigella Sonnel O-SPC/rBRU Conjugate Vaccine (NCT01369927)Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2011-05-15
GSK1521498 Alcohol Interaction Study (NCT01366573)GlaxoSmithKline2011-05-13
Study to Compare the Bioavailability of Dutasteride Novel Formulation Form to the Soft Gel Capsule Form in Healthy Male Subjects (NCT01577693)GlaxoSmithKline2011-05-12
A Study Of PF-04449913 Administered Alone In Select Solid Tumors (NCT01286467)Pfizer2011-05-11
SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma (NCT01362790)National Cancer Institute (NCI)2011-05-11
Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal Cancer (NCT01061515)Washington University School of Medicine2011-05-10
EBV CTLs Expressing CD30 Chimeric Receptors For CD 30+ Lymphoma (NCT01192464)Baylor College of Medicine2011-05-10
Bacterial Properties With LoFric® Catheters During Clean Intermittent Catheterization (NCT01305681)Nationwide Children's Hospital2011-05-06
Study of ABT-767 in Subjects With Breast Cancer 1 and Breast Cancer 2 (BRCA 1 and BRCA 2) Mutations and Solid Tumors or High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT01339650)AbbVie (prior sponsor, Abbott)2011-05-06
Bendamustine, Wkly Bortezomib, Lenalidomide and Dexamethasone for Multiple Myeloma (NCT01484626)Loyola University2011-05-05
Cyclophosphamide and Veliparib in Treating Patients With Locally Advanced or Metastatic Breast Cancer (NCT01351909)National Cancer Institute (NCI)2011-05-02
Study of Carfilzomib for Multiple Myeloma Patients Who Are Relapsed/Refractory to Bortezomib-containing Treatments (NCT01365559)Oncotherapeutics2011-05-02
GSK1120212 Food-effect Study (NCT01371487)GlaxoSmithKline2011-05-02
Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Participants With Solid Tumors (NCT01311713)Teva Branded Pharmaceutical Products R&D, Inc.2011-05-02
A Study of LY2603618 in Combination With Gemcitabine in Participants With Solid Tumors (NCT01341457)Eli Lilly and Company2011-05-01
A Study of TRU-016 in Combination With Rituximab and Bendamustine in Subjects With Relapsed Indolent Lymphoma (NCT01317901)Aptevo Therapeutics2011-05-01
Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors (NCT01401933)Abbott2011-05-01
Amorphous Calcium Carbonate (Acc) Versus Crystalline Calcium Carbonate (Ccc) Using Stable Calcium Isotopes In Postmenopausal Women (NCT01338142)Tel-Aviv Sourasky Medical Center2011-05-01
A Study in Healthy Volunteers Comparing Two Different Liquid Formulations of Solifenacin With Each Other and With the Tablet Formulation (NCT01406158)Astellas Pharma Inc2011-05-01
Evaluation of Intravenous Ascorbic Acid (NCT01833351)University of Kansas Medical Center2011-05-01
Autologous Bone Marrow Mononuclear Cell Transplantation in Treating Type 2 Diabetes Mellitus (NCT01677013)Peking University Aerospace Center Hospital2011-05-01
A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent Glioblastoma (NCT01308684)Hoffmann-La Roche2011-05-01
Effect of Carum Carvi on Thyroid Hormones and TSH Level (NCT01471288)Mashhad University of Medical Sciences2011-05-01
A Study of the Safety and Efficacy of ONO-7746 in Adult Cancer Patients With Chemotherapy Induced Thrombocytopenia (NCT01345214)Ono Pharma USA Inc2011-05-01
Multiple Ascending Dose Study of SPC5001 in Treatment of Healthy Subjects and Subjects With FH (NCT01350960)Santaris Pharma A/S2011-05-01
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.